Vesugen

Blood vessels Research only Human trials Synthetic short peptide (Cytogen)

Also called KED peptide

A three-amino-acid Khavinson peptide associated with the lining of blood vessels. Studies report effects on endothelial cell growth and on markers tied to atherosclerosis, with related work on neuron resilience in models of aging.

Why people take it

Vascular healthAtherosclerosisNeuron resilience

What studies report

Worth knowing: Cell and animal data plus small Russian studies.

Status: Cell and animal data, plus small Russian human studies.

Route
Subcutaneous injection, or oral capsule depending on the preparation
Sequence
Lys-Glu-Asp
Formula
C15H26N4O8
Molecular weight
390.39 g/mol
Available as
20 mg
View on PubChem →

Educational information only. Nothing here is medical advice, a dosing protocol, or a recommendation to use any compound. Most entries describe substances not approved for human use. Talk to a licensed clinician before acting on anything you read here. How to read these entries.